Also of interest
-
Gene therapy in sickle cell and thalassaemia – where cutting-edge science meets clinical need
What does the approval for human use of new gene editing techniques mean for patients?
An audit of compliance with the BCSH guideline on the first line management of classical Hodgkin lymphoma (cHL)
April 2016